Afya Ltd. Form 20-F Summary (Fiscal Year Ended December 31, 2024)
Business Context and Reporting Period
Afya Ltd. is a Cayman Islands exempted company and the leading medical education group in Brazil by number of private medical school seats. The company operates an end-to-end physician-centric ecosystem comprising three segments: Undergrad (medical and health sciences undergraduate programs), Continuing Education (residency preparation and graduate courses), and Medical Practice Solutions (digital health services). The reporting period covers the fiscal year ended December 31, 2024. The company is a foreign private issuer listed on the Nasdaq Global Select Market under the symbol "AFYA."
Key Financial Metrics
| Metric (R$ millions) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3,304.3 | 2,875.9 | 2,329.1 |
| Net Income | 648.9 | 405.4 | 392.8 |
| Adjusted EBITDA | 1,455.6 | 1,165.7 | 961.9 |
| Operating Cash Flow | 1,432.7 | 1,043.6 | 843.9 |
| Cash and Cash Equivalents (Year End) | 911.0 | 553.0 | 1,093.1 |
| Total Debt (Loans & Financing) | 2,195.2 | 1,800.8 | N/A |
| Operating Cash Conversion Ratio | 102.2% | 97.1% | 94.4% |
Note: All figures are in Brazilian Reais (R$). Convenience translations to USD are provided in the filing using the rate of R$6.1923 per US$1.00 as of December 31, 2024.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 14.9% year-over-year to R$3,304.3 million, driven by a 15.3% increase in the Undergrad segment (due to the Unidom acquisition and seat maturation) and a 15.3% increase in Medical Practice Solutions.
- Profitability: Net income surged 60.1% to R$648.9 million, aided by a decrease in the effective tax rate from 5.62% to 4.10% due to increased PROUNI fiscal incentives.
- Acquisitions: The company acquired Unidom Participações S.A. in July 2024 for R$620.8 million, adding 300 medical school seats (125 final, 175 subject to court proceedings). This acquisition contributed R$63.6 million to revenue in 2024.
- Debt Profile: Total loans and financing increased to R$2,195.2 million, primarily due to a new R$500 million sustainability-linked loan from the International Finance Corporation (IFC) in August 2024.
- Dividends: On March 12, 2025, the Board approved the company's first-ever dividend distribution of R$129.8 million (R$1.35 per share), payable in April 2025.
Guidance, Outlook, and Risks
Outlook and Strategy: Afya expects continued growth through the maturation of its medical school seats (reaching full capacity over a six-year cycle) and the expansion of its Continuing Education and Medical Practice Solutions segments. The company plans to open an additional campus in 2025 under the "Mais Médicos" program and is evaluating further M&A opportunities, including a signed agreement to acquire FUNIC (expected closing May 2025).
Key Risks and Contingencies:
- Regulatory Environment: The company is highly dependent on the Brazilian Ministry of Education (MEC) for seat authorizations. A significant portion of Unidom's seats (175) remains subject to final court rulings. Changes to the "Mais Médicos" program or tax exemptions under PROUNI could materially impact operations.
- Taxation: Brazil enacted Law 15,079/2024 implementing the OECD Pillar Two global minimum tax (15%) effective January 1, 2025. Afya is assessing the impact and has filed a writ of mandamus challenging the enforceability of the additional tax.
- Macroeconomic Factors: Operations are exposed to Brazilian inflation, interest rate fluctuations (SELIC rate was 14.25% as of the report date), and exchange rate volatility (Real depreciated 27.9% against the USD in 2024).
- Legal Proceedings: The company has provisions of R$113.5 million for probable losses in legal proceedings (labor, civil, and tax) and R$106.3 million for possible losses not yet provisioned.
Investor Verification Checklist
- Unidom Seat Authorization: Verify the status of the court proceedings regarding the 175 medical school seats acquired via Unidom, as contingent consideration payments depend on their maintenance.
- Pillar Two Tax Impact: Monitor the outcome of the company's legal challenge against the new OECD Pillar Two tax and quantify the potential increase in the effective tax rate for 2025.
- PROUNI Compliance: Confirm continued compliance with PROUNI scholarship requirements to maintain critical federal tax exemptions (IRPJ, CSLL, PIS, COFINS).
- Debt Covenants: Review compliance with financial covenants, specifically the Net Debt to Adjusted EBITDA ratio (capped at 3.0x) under the IFC loan and debenture agreements.
- Exchange Rate Sensitivity: Assess the impact of the Brazilian Real's volatility on USD-denominated financial reporting and future dividend payments.